Roivant Sciences ROIV
$38.66 −$0.31 (-0.78%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $38.68 +0.06%
Open$38.86
Prev close$38.96
Day range$38.46 – $39.51
Volume3.97M
Market cap$28.01B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$35.12M+2,135.6% YoY
Operating profit-$268.05M+12.5% YoY
Net profit-$137.21M+17.4% YoY
Diluted EPS-$0.27-58.8% YoY
Free cash flow$594.21M+407.1% YoY
Operating cash flow$594.42M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin88.7%
Operating margin-3,234.0%
Net margin-838.2%
Return on equity-8.2%
Return on assets-6.9%
Return on invested capital-10.9%
Current ratio15.56
Liabilities / assets100.0%
Total debt$92.79M
Income statement
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $35.12M | $1.44M | $8.26M | $2.52M | $2.00M |
| Total Operating Revenue | $35.12M | $1.44M | $8.26M | $2.52M | $2.00M |
| Cost of Revenue | $3.35M | $284,000.00 | $1.29M | $320,000.00 | $700,000.00 |
| Gross Profit | $31.77M | $1.16M | $6.98M | $2.20M | $1.30M |
| Operating Expense | $299.82M | $367.54M | $1.29B | $357.20M | $340.45M |
| Selling and Admin Expenses | $154.08M | $165.53M | $610.47M | $158.25M | $175.07M |
| Research & Development | $145.75M | $202.02M | $681.81M | $198.95M | $165.38M |
| Operating Profit | -$268.05M | -$366.39M | -$1.29B | -$355.00M | -$339.15M |
| Net Non-Operating Interest Income (Expense) | $41.61M | $36.92M | $178.11M | $41.18M | $43.27M |
| Non-Operating Interest Income | $41.61M | $36.92M | $178.11M | $41.18M | $43.27M |
| Other Income (Expense) | $60.09M | $34.90M | $842.62M | $767.91M | $5.52M |
| Gain on Sale of Security | $60.29M | $36.64M | $105.05M | -$25.92M | $21.59M |
| Special Income (Charges) | $0.00 | $392,000.00 | $781.26M | $781.26M | $0.00 |
| Other Non-Operating Income (Expenses) | -$200,000.00 | -$2.13M | -$43.69M | $12.57M | -$16.07M |
| Pretax Profit | -$166.35M | -$294.56M | -$264.58M | $454.10M | -$290.37M |
| Tax | -$13.37M | -$3.96M | $133.33M | $98.35M | $23.33M |
| Net Profit | -$137.21M | -$290.61M | -$397.91M | $355.74M | -$313.70M |
| Profit from Continuing Operations | -$152.97M | -$290.61M | -$397.91M | $355.74M | -$313.70M |
| Net Income from Discontinuous Operations | $15.76M | – | $0.00 | $0.00 | $0.00 |
| Minority Interests | $54.41M | -$100.77M | -$98.14M | $52.75M | -$47.81M |
| Net Income to Parent Company | -$191.62M | -$189.84M | -$299.77M | $302.99M | -$265.89M |
| Net Income to Common Stockholders | -$191.62M | -$189.84M | -$299.77M | $302.99M | -$265.89M |
| Basic EPS | -$0.27 | -$0.26 | -$0.43 | $0.43 | -$0.38 |
| Diluted EPS | -$0.27 | -$0.26 | -$0.54 | $0.28 | -$0.38 |
| -General & Admin Expense | – | $165.53M | $610.47M | $158.25M | $175.07M |
| -Less:Other Special Charges | – | -$392,000.00 | -$770.24M | – | – |
| -Gain on Sale Of Business | – | – | $11.03M | $11.03M | $0.00 |
Balance sheet
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Assets | $4.98B | $5.31B | $5.71B | $5.71B | $5.23B |
| Total Current Assets | $4.36B | $4.74B | $5.17B | $5.17B | $4.66B |
| Other Current Assets | $4.36B | $128.37M | $105.32M | $105.32M | $129.91M |
| Total Non-Current Assets | $620.28M | $564.41M | $541.30M | $541.30M | $565.48M |
| Other Non-Current Assets | $620.28M | $29.59M | $40.92M | $40.92M | $34.56M |
| Total Liabilities | $4.98B | $384.62M | $416.28M | $416.28M | $251.14M |
| Total Current Liabilities | $279.91M | $283.60M | $281.24M | $281.24M | $151.96M |
| -Accounts Payable | $11.30M | $25.08M | $18.00M | $18.00M | $13.29M |
| Current Accrued Expenses | $132.22M | $127.92M | $118.50M | $118.50M | $79.88M |
| -Current Capital Lease Obligation | $13.78M | $12.38M | $11.15M | $11.15M | $10.44M |
| Other Current Liabilities | $279.91M | $3.21M | $583,000.00 | $583,000.00 | $26,000.00 |
| Long Term Debt and Capital Lease Obligation | $92.79M | $94.77M | $96.29M | $96.29M | $98.50M |
| -Long Term Capital Lease Obligation | $92.79M | $94.77M | $96.29M | $96.29M | $98.50M |
| Stockholders' Equity | $4.02B | $4.23B | $4.53B | $4.53B | $4.27B |
| Additional Paid-In Capital | $5.19B | $5.13B | $5.02B | $5.02B | $4.94B |
| Retained Earnings | -$1.16B | -$900.35M | -$501.81M | -$501.81M | -$695.00M |
| Other Equity Interests | $5.18B | – | – | – | – |
| Minority Interests | $575.41M | $690.60M | $765.04M | $765.04M | $704.97M |
| Cash and Cash Equivalents & Short-Term Investments | – | $3.84B | $4.29B | $4.29B | $4.53B |
| -Cash and Cash Equivalents | – | $1.25B | $1.42B | $1.42B | $1.48B |
| -Short Term Investments | – | $2.59B | $2.87B | $2.87B | $3.05B |
| Receivables | – | $771.63M | $770.24M | $770.24M | – |
| -Other Receivables | – | $771.63M | $770.24M | $770.24M | – |
| Net PPE | – | $90.21M | $92.40M | $92.40M | $97.01M |
| -Gross PPE | – | $90.21M | $92.40M | $92.40M | $97.01M |
| Investments and Advances | – | $444.62M | $407.99M | $407.99M | $433.91M |
| Payables | – | $99.27M | $63.69M | $63.69M | $20.46M |
| -Total Tax Payable | – | $74.18M | $45.69M | $45.69M | $7.17M |
| Short-Term Debt and Capital Lease Obligation | – | $12.38M | $11.15M | $11.15M | $10.44M |
| Total Non-Current Liabilities | – | $101.02M | $135.03M | $135.03M | $99.18M |
| Long Term Accounts Payable and Other Payables | – | $0.00 | $38.67M | $38.67M | – |
| Other Non-Current Liabilities | – | $6.25M | $70,000.00 | $70,000.00 | $677,000.00 |
| Total Equity | – | $4.92B | $5.29B | $5.29B | $4.97B |
| Capital Stock | – | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Gains/Losses Not Affecting Retained Earnings | – | $701,000.00 | $4.36M | $4.36M | $20.61M |
| Current Deferred Liabilities | – | – | – | – | $3.05M |
Cash flow
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $594.42M | -$270.50M | -$750.35M | -$163.82M | -$196.48M |
| Net cash flow from continuing operations | $594.42M | -$270.50M | -$750.35M | -$163.82M | -$196.48M |
| Net Income from Continuing Operations | -$137.21M | -$290.61M | -$397.91M | $355.74M | -$313.70M |
| Depreciation & Depletion & Amortization | $604,000.00 | $600,000.00 | $3.35M | $638,000.00 | $691,000.00 |
| Other Non-Cash Items | $5.51M | $11.18M | $57.81M | $25.95M | $10.91M |
| Change in Working Capital | $727.19M | -$32.70M | -$621.80M | -$601.08M | $9.37M |
| -Change in Receivables | $771.63M | -$1.39M | -$770.24M | – | – |
| -Change in Payables and Accrued Expense | -$9.73M | -$16.98M | $147.79M | $164.43M | $4.59M |
| -Change in Other Current Assets | -$31.37M | -$21.97M | $4.04M | $11.04M | $658,000.00 |
| -Change in Other Current Liabilities | -$3.34M | $7.64M | -$3.39M | -$1.28M | -$903,000.00 |
| Net cash flow from investing | $42.54M | $281.26M | -$682.33M | $173.49M | $109.47M |
| Net Cash Flow from Continuing Investing Activities | $42.54M | $281.26M | -$682.33M | $173.49M | $109.47M |
| Net PPE Purchase and Sale | -$208,000.00 | -$419,000.00 | -$8.21M | -$1.26M | $4.94M |
| Net Investment Purchase and Sale | $23.47M | $281.68M | -$667.19M | $179.17M | $107.05M |
| Financing Cash Flow | -$249.21M | -$181.51M | $134.24M | -$68.78M | $328.19M |
| Net Cash Flow from Continuing Financing Activities | -$249.21M | -$181.51M | $134.24M | -$68.78M | $328.19M |
| Net Common Stock Issuance | -$74.47M | -$206.73M | -$125.90M | -$111.21M | $193.61M |
| Proceeds from Stock Option Exercised | $25.42M | $76.65M | $269.51M | $51.19M | $119.20M |
| Net Other Financing Charges | -$200.16M | -$51.44M | -$9.37M | -$8.75M | $15.39M |
| Ending Cash Balance | $1.65B | $1.26B | $1.43B | $1.43B | $1.49B |
| Net Change in Cash | $387.74M | -$170.75M | -$1.30B | -$59.10M | $241.18M |
| Beginning Cash Balance | $1.26B | $1.43B | $2.73B | $1.49B | $1.25B |
| Effect of Exchange Rate Changes | $1.30M | $315,000.00 | $3.77M | $1.32M | $430,000.00 |
| Free Cash Flow | $594.21M | -$270.92M | -$758.56M | -$165.08M | -$191.55M |
| Gain/Loss from Continuing Operations | – | – | -$12.00M | -$11.66M | – |
| Net Business Purchase and Sale | – | – | -$4.42M | -$4.42M | $0.00 |
| Net Other Investing Changes | – | – | -$2.52M | $0.00 | – |
| Net Issuance Payments Of Debt | – | – | $0.00 | $0.00 | $0.00 |
| -Change In Other Working Capital | – | – | – | – | $8.30M |
No comments yet — be the first to weigh in on ROIV.
Sign in to join the discussion.